Embark Ventures — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.
BiotechDeep TechHardwareMedical DevicesAtlanta, US
Alla Zamarayeva(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Todd Sulchek(CSO & Co-founder)inAlex Alexeev(Co-founder)in
Co-investorsDynamk CapitalCota CapitalCreative Destruction Lab (CDL)Elm Street VenturesGreatPoint VenturesM Ventures+1 more
Parallel manufactures automated, battery-electric rail vehicles to enable railroads to serve shorter routes and lower-density markets traditionally served by trucking.
CleantechHardwareLogistics & Supply ChainLos Angeles, US
John Howard(Executive Officer, Director)inBenjamin Stabler(Founder)inMatt Soule(Founder)inBen Stabler(Founder)John D. Howard(Founder)
BoardJoshua Posamentier(Director)in
Co-investorsCollaborative FundCongruent VenturesInterwoven VenturesRiot VenturesAnthos Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














